My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 150

    1.

    Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.

    Hansen AM, Christensen IT, Hansen JB, Carr RD, Ashcroft FM, Wahl P.

    Diabetes. 2002 Sep;51(9):2789-95.PMID: 12196472 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.

    Hansen AM, Hansen JB, Carr RD, Ashcroft FM, Wahl P.

    Br J Pharmacol. 2005 Feb;144(4):551-7.PMID: 15678092 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.

    Hu S, Wang S, Fanelli B, Bell PA, Dunning BE, Geisse S, Schmitz R, Boettcher BR.

    J Pharmacol Exp Ther. 2000 May;293(2):444-52.PMID: 10773014 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.

    Chachin M, Yamada M, Fujita A, Matsuoka T, Matsushita K, Kurachi Y.

    J Pharmacol Exp Ther. 2003 Mar;304(3):1025-32.PMID: 12604678 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.

    Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S.

    Eur J Pharmacol. 2001 Nov 9;431(1):119-25.PMID: 11716850 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.

    Dabrowski M, Wahl P, Holmes WE, Ashcroft FM.

    Diabetologia. 2001 Jun;44(6):747-56.PMID: 11440368 [PubMed - indexed for MEDLINE]Related articles

    7.

    Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.

    Winkler M, Stephan D, Bieger S, Kühner P, Wolff F, Quast U.

    J Pharmacol Exp Ther. 2007 Aug;322(2):701-8. Epub 2007 May 10.PMID: 17495126 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.

    Gribble FM, Tucker SJ, Seino S, Ashcroft FM.

    Diabetes. 1998 Sep;47(9):1412-8.PMID: 9726229 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.

    Reimann F, Dabrowski M, Jones P, Gribble FM, Ashcroft FM.

    J Physiol. 2003 Feb 15;547(Pt 1):159-68. Epub 2003 Jan 10.PMID: 12562963 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells.

    Bokvist K, Hoy M, Buschard K, Holst JJ, Thomsen MK, Gromada J.

    Eur J Pharmacol. 1999 Dec 10;386(1):105-11.PMID: 10611470 [PubMed - indexed for MEDLINE]Related articles

    11.

    Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.

    Stephan D, Winkler M, Kühner P, Russ U, Quast U.

    Diabetologia. 2006 Sep;49(9):2039-48. Epub 2006 Jul 25.PMID: 16865362 [PubMed - indexed for MEDLINE]Related articles

    12.

    Nateglinide, but not repaglinide, stimulates growth hormone release in rat pituitary cells by inhibition of K channels and stimulation of cyclic AMP-dependent exocytosis.

    Gromada J, Bokvist K, Høy M, Olsen HL, Lindström P, Hansen BS, Gotfredsen CF, Rorsman P, Thomsen MK.

    Eur J Endocrinol. 2002 Jul;147(1):133-42.PMID: 12088930 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.

    Gopalakrishnan M, Molinari EJ, Shieh CC, Monteggia LM, Roch JM, Whiteaker KL, Scott VE, Sullivan JP, Brioni JD.

    Br J Pharmacol. 2000 Apr;129(7):1323-32.PMID: 10742287 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Sensitivity of Kir6.2-SUR1 currents, in the absence and presence of sodium azide, to the K(ATP) channel inhibitors, ciclazindol and englitazone.

    McKay NG, Kinsella JM, Campbell CM, Ashford ML.

    Br J Pharmacol. 2000 Jun;130(4):857-66.PMID: 10864893 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Sulfonylurea induced beta-cell apoptosis in cultured human islets.

    Maedler K, Carr RD, Bosco D, Zuellig RA, Berney T, Donath MY.

    J Clin Endocrinol Metab. 2005 Jan;90(1):501-6. Epub 2004 Oct 13.PMID: 15483097 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The mechanisms underlying the unique pharmacodynamics of nateglinide.

    Hu S, Boettcher BR, Dunning BE.

    Diabetologia. 2003 Mar;46 Suppl 1:M37-43. Epub 2002 Nov 8. Review.PMID: 12652357 [PubMed - indexed for MEDLINE]Related articles

    17.

    Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of beta-cells.

    Schwanstecher C, Meyer M, Schwanstecher M, Panten U.

    Br J Pharmacol. 1998 Mar;123(6):1023-30.PMID: 9559882 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.

    Gribble FM, Reimann F.

    J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):11-5. Review.PMID: 12623163 [PubMed - indexed for MEDLINE]Related articles

    19.

    Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.

    Lim JG, Lee HY, Yun JE, Kim SP, Park JW, Suh SI, Jang BC, Cho CH, Bae JH, Kim SS, Han J, Park MJ, Song DK.

    Biochem Pharmacol. 2004 Sep 1;68(5):901-10.PMID: 15294453 [PubMed - indexed for MEDLINE]Related articles

    20.

    Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.

    Ashfield R, Gribble FM, Ashcroft SJ, Ashcroft FM.

    Diabetes. 1999 Jun;48(6):1341-7.PMID: 10342826 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity